- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x GLY: GLYCINE(Non-covalent)
GLY.6: 9 residues within 4Å:- Chain A: S.191, F.192, Y.235, T.237, F.240
- Chain B: F.96, R.98, L.150, S.162
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:F.192, A:T.237, B:S.162
- Salt bridges: B:R.98
GLY.16: 9 residues within 4Å:- Chain A: F.96, R.98, L.150, S.162
- Chain E: S.191, F.192, Y.235, T.237, F.240
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain E- Hydrogen bonds: A:S.162, E:F.192, E:T.237
- Salt bridges: A:R.98
GLY.17: 9 residues within 4Å:- Chain B: S.191, F.192, Y.235, T.237, F.240
- Chain C: F.96, R.98, L.150, S.162
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain B- Hydrogen bonds: C:S.162, B:F.192, B:T.237
- Salt bridges: C:R.98
GLY.27: 9 residues within 4Å:- Chain C: S.191, F.192, Y.235, T.237, F.240
- Chain D: F.96, R.98, L.150, S.162
4 PLIP interactions:2 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: D:S.162, C:F.192, C:T.237
- Salt bridges: D:R.98
GLY.37: 9 residues within 4Å:- Chain D: S.191, F.192, Y.235, T.237, F.240
- Chain E: F.96, R.98, L.150, S.162
4 PLIP interactions:2 interactions with chain D, 2 interactions with chain E- Hydrogen bonds: D:F.192, D:T.237, E:S.162
- Salt bridges: E:R.98
- 25 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-covalent)
PIO.7: 2 residues within 4Å:- Chain A: W.448
- Ligands: PIO.9
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:W.448
PIO.8: 3 residues within 4Å:- Chain A: L.265
- Ligands: PIO.9, PIO.47
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.265
PIO.9: 4 residues within 4Å:- Chain A: L.257, W.448
- Ligands: PIO.7, PIO.8
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.257
- Salt bridges: A:K.452
PIO.10: 1 residues within 4Å:- Chain A: W.276
No protein-ligand interaction detected (PLIP)PIO.12: 5 residues within 4Å:- Chain A: S.311, V.313
- Chain B: I.258, I.262
- Ligands: PIO.19
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:V.313, B:I.258, B:I.262
PIO.18: 2 residues within 4Å:- Chain B: W.448
- Ligands: PIO.20
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:W.448
PIO.19: 3 residues within 4Å:- Chain B: L.265
- Ligands: PIO.12, PIO.20
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.265
PIO.20: 4 residues within 4Å:- Chain B: L.257, W.448
- Ligands: PIO.18, PIO.19
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:L.257
- Salt bridges: B:K.452
PIO.21: 1 residues within 4Å:- Chain B: W.276
No protein-ligand interaction detected (PLIP)PIO.23: 5 residues within 4Å:- Chain B: S.311, V.313
- Chain C: I.258, I.262
- Ligands: PIO.29
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:V.313, C:I.258, C:I.262
PIO.28: 2 residues within 4Å:- Chain C: W.448
- Ligands: PIO.30
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:W.448
PIO.29: 3 residues within 4Å:- Chain C: L.265
- Ligands: PIO.23, PIO.30
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.265
PIO.30: 4 residues within 4Å:- Chain C: L.257, W.448
- Ligands: PIO.28, PIO.29
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:L.257
- Salt bridges: C:K.452
PIO.31: 1 residues within 4Å:- Chain C: W.276
No protein-ligand interaction detected (PLIP)PIO.33: 5 residues within 4Å:- Chain C: S.311, V.313
- Chain D: I.258, I.262
- Ligands: PIO.39
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:I.258, D:I.262, C:V.313
PIO.38: 2 residues within 4Å:- Chain D: W.448
- Ligands: PIO.40
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:W.448
PIO.39: 3 residues within 4Å:- Chain D: L.265
- Ligands: PIO.33, PIO.40
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:L.265
PIO.40: 4 residues within 4Å:- Chain D: L.257, W.448
- Ligands: PIO.38, PIO.39
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:L.257
- Salt bridges: D:K.452
PIO.41: 1 residues within 4Å:- Chain D: W.276
No protein-ligand interaction detected (PLIP)PIO.43: 5 residues within 4Å:- Chain D: S.311, V.313
- Chain E: I.258, I.262
- Ligands: PIO.52
3 PLIP interactions:2 interactions with chain E, 1 interactions with chain D- Hydrophobic interactions: E:I.258, E:I.262, D:V.313
PIO.47: 5 residues within 4Å:- Chain A: I.258, I.262
- Chain E: S.311, V.313
- Ligands: PIO.8
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain E- Hydrophobic interactions: A:I.258, A:I.262, E:V.313
PIO.51: 2 residues within 4Å:- Chain E: W.448
- Ligands: PIO.53
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:W.448
PIO.52: 3 residues within 4Å:- Chain E: L.265
- Ligands: PIO.43, PIO.53
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:L.265
PIO.53: 4 residues within 4Å:- Chain E: L.257, W.448
- Ligands: PIO.51, PIO.52
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:L.257
- Salt bridges: E:K.452
PIO.54: 1 residues within 4Å:- Chain E: W.276
No protein-ligand interaction detected (PLIP)- 20 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PX4.11: 5 residues within 4Å:- Chain A: I.269, W.276
- Chain E: L.332, F.339
- Ligands: PX4.50
Ligand excluded by PLIPPX4.13: 5 residues within 4Å:- Chain A: I.318, I.442, F.443, I.450, Y.451
Ligand excluded by PLIPPX4.14: 6 residues within 4Å:- Chain A: L.325, F.326, I.431, C.435, F.436
- Ligands: PX4.15
Ligand excluded by PLIPPX4.15: 3 residues within 4Å:- Chain A: S.329
- Ligands: PX4.14, PX4.22
Ligand excluded by PLIPPX4.22: 5 residues within 4Å:- Chain A: L.332, F.339
- Chain B: I.269, W.276
- Ligands: PX4.15
Ligand excluded by PLIPPX4.24: 5 residues within 4Å:- Chain B: I.318, I.442, F.443, I.450, Y.451
Ligand excluded by PLIPPX4.25: 5 residues within 4Å:- Chain B: L.325, F.326, C.435, F.436
- Ligands: PX4.26
Ligand excluded by PLIPPX4.26: 3 residues within 4Å:- Chain B: S.329
- Ligands: PX4.25, PX4.32
Ligand excluded by PLIPPX4.32: 5 residues within 4Å:- Chain B: L.332, F.339
- Chain C: I.269, W.276
- Ligands: PX4.26
Ligand excluded by PLIPPX4.34: 5 residues within 4Å:- Chain C: I.318, I.442, F.443, I.450, Y.451
Ligand excluded by PLIPPX4.35: 6 residues within 4Å:- Chain C: L.325, F.326, I.431, C.435, F.436
- Ligands: PX4.36
Ligand excluded by PLIPPX4.36: 3 residues within 4Å:- Chain C: S.329
- Ligands: PX4.35, PX4.42
Ligand excluded by PLIPPX4.42: 5 residues within 4Å:- Chain C: L.332, F.339
- Chain D: I.269, W.276
- Ligands: PX4.36
Ligand excluded by PLIPPX4.44: 5 residues within 4Å:- Chain D: I.318, I.442, F.443, I.450, Y.451
Ligand excluded by PLIPPX4.45: 5 residues within 4Å:- Chain D: L.325, F.326, C.435, F.436
- Ligands: PX4.46
Ligand excluded by PLIPPX4.46: 3 residues within 4Å:- Chain D: S.329
- Ligands: PX4.45, PX4.55
Ligand excluded by PLIPPX4.48: 5 residues within 4Å:- Chain E: I.318, I.442, F.443, I.450, Y.451
Ligand excluded by PLIPPX4.49: 6 residues within 4Å:- Chain E: L.325, F.326, I.431, C.435, F.436
- Ligands: PX4.50
Ligand excluded by PLIPPX4.50: 3 residues within 4Å:- Chain E: S.329
- Ligands: PX4.11, PX4.49
Ligand excluded by PLIPPX4.55: 5 residues within 4Å:- Chain D: L.332, F.339
- Chain E: I.269, W.276
- Ligands: PX4.46
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kindig, K. et al., Physiological modulation of alpha3 glycine receptors. To Be Published
- Release Date
- 2024-11-13
- Peptides
- Glycine receptor subunit alpha-3: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x GLY: GLYCINE(Non-covalent)
- 25 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-covalent)
- 20 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kindig, K. et al., Physiological modulation of alpha3 glycine receptors. To Be Published
- Release Date
- 2024-11-13
- Peptides
- Glycine receptor subunit alpha-3: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.